NCT03066466 2021-04-27
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
Loyola University
Phase 3 Withdrawn
Loyola University
Novartis
Masonic Cancer Center, University of Minnesota
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)